Stay updated on Retinal Imaging With NOTAL-OCT V2.5 Clinical Trial
Sign up to get notified when there's something new on the Retinal Imaging With NOTAL-OCT V2.5 Clinical Trial page.

Latest updates to the Retinal Imaging With NOTAL-OCT V2.5 Clinical Trial page
- Check6 days agoChange DetectedThe record describes a completed observational study evaluating the NOTAL-OCT V2.5 device against commercial OCT for retinal imaging in patients with AMD or diabetic retinopathy. It also provides participant eligibility, study design and outcomes, location, and registration history.SummaryDifference31%

- Check13 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0 while the study record remains inaccessible.SummaryDifference0.2%

- Check20 days agoChange DetectedA site-wide banner announces NIH terminology and website-transition updates. The clinical trial record remains inaccessible behind a 403 error.SummaryDifference1%

- Check26 days agoChange DetectedThe displayed ClinicalTrials.gov revision changed from v3.7.1 to v3.7.2 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check34 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the expected study content, indicating an access restriction. While navigation and layout remain, no study details are accessible.SummaryDifference15%

Stay in the know with updates to Retinal Imaging With NOTAL-OCT V2.5 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Retinal Imaging With NOTAL-OCT V2.5 Clinical Trial page.